CVRdatabase
Menu

Evaxion A/S

Public limited companyCVR 31762863HørsholmActive

Evaxion A/S is a public limited company, based in Hørsholm, active in research and experimental development on natural sciences and engineering, founded in 2008. The company made a loss in both 2024 and 2025, most recently DKK 51.5m. With 46 employees, the company is about 9 times larger than the industry median. Gross profit is higher than that of 92% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 48.1m+111.4% vs. 2024
Net profit−DKK 51.5m+29.7% vs. 2024
EquityDKK 108.3m+1,018.9% vs. 2024
Employees46latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 111% (2024 → 2025), to DKK 48.1m.
  • Revenue rose 111% (2024 → 2025), to DKK 48.1m.
  • The loss got smaller: from DKK 73.3m to DKK 51.5m (2024 → 2025).
  • Equity turned positive again: DKK 108.3m (2024 → 2025).

Employees

  • 11 fewer employees than a year earlier: 46 (08/2026) against 57 (08/2025).

Management and owners, last 24 months

  • New in management: Thomas Frederik Schmidt (director, 01/11/2024), Helen Katrina Tayton-Martin (ceo, 24/11/2025) and Jens Bitsch-Nørhave (board member, 16/04/2026) (+2).
  • Stepped down: Jesper Nyegaard Nissen (director, 31/10/2024), Christian Kanstrup (ceo, 30/06/2025) and Helen Katrina Tayton-Martin (board member, 24/11/2025) (+1).
  • New owners registered: BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) (31/01/2025).
  • No longer registered as owner: Nimedical Holding ApS (27/01/2025), Mattsson Holding af 2008 ApS (27/01/2025) and BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) (30/01/2025).

Registrations, last 24 months

  • 22/10/2026: Share capital changed from 115,095,102 DKK to 115,283,514 DKK
  • 21/10/2026: Share capital changed from 112,964,777 DKK to 115,095,102 DKK
  • 20/10/2026: Share capital changed from 112,768,539 DKK to 112,964,777 DKK
  • 24/08/2026: Share capital changed from 110,933,302 DKK to 112,768,539 DKK
  • 21/08/2026: Share capital changed from 110,565,252 DKK to 110,933,302 DKK
  • 20/08/2026: Share capital changed from 104,252,689 DKK to 110,565,252 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 200m−DKK 150m−DKK 100m−DKK 50mDKK 0DKK 50mDKK 100mDKK 150mDKK 200m202020212022202320242025
EquityNet profit
Financial figures for Evaxion A/S
202020212022202320242025Change
Revenuenot statednot statednot stated50722,75948,112+111.4%
Gross profit–––50722,75948,112+111.4%
Operating profit (EBIT)−92,847−183,407−180,483−152,895−101,838−62,798+38.3%
Profit before tax−103,418−160,415−169,792−157,855−78,730−56,989+27.6%
Net profit−97,918−154,885−164,292−152,414−73,277−51,489+29.7%
Total assets70,493263,012150,43786,92889,197180,463+102.3%
Equity42,615212,81857,888−31,893−11,780108,250+1,018.9%
Liabilities27,87850,19492,549117,81499,97071,206−28.8%
Cash and cash equivalents34,758209,64185,23737,65142,523147,596+247.1%
Average number of employees33–59554645−2.2%

Source: annual reports filed with the Danish Business Authority (XBRL). Group figures; change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Evaxion A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/04/2026The groupPDF not statedXBRL
202401/01/2024 – 31/12/202401/05/2025The groupPDFXBRL
202301/01/2023 – 31/12/202318/04/2024The groupPDFXBRL
202201/01/2022 – 31/12/202207/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202123/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202004/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304050607009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 48.1mNo. 34 of 421
Better than 92% of the companies in the industry
EquityDKK 108.3mNo. 32 of 431
Better than 93% of the companies in the industry
Number of employees46No. 45 of 431
Better than 90% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 471of 9,892
Better than 95%
No. 317of 9,922
Better than 97%
Same industry and 20–49 employees64 companies in the comparison
No. 5of 62
Better than 93%
No. 12of 64
Better than 83%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 1,478of 24,791
Better than 94%
No. 1,267of 24,909
Better than 95%
All companies of type A/S18,025 companies in the comparison
No. 3,012of 17,786
Better than 83%
No. 2,146of 18,024
Better than 88%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Evaxion A/SDKK 48.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Evaxion A/S−DKK 51.5m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Evaxion A/SDKK 108.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Evaxion A/S46
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon)90%
Evaxion A/S

Management

8 active registrations

Executive management

Executive management at Evaxion A/S
NameRoleAppointed
Andreas Holm MattssonDirector11/08/2008
Thomas Frederik SchmidtDirector01/11/2024
Helen Katrina Tayton-MartinCEO24/11/2025

Board of directors

Board of directors at Evaxion A/S
NameRoleAppointed
Roberto Prego PinedaBoard member01/06/2018
Marianne SøgaardChair of the board25/11/2020
Lars HoltugBoard member25/05/2021
Lars Aage Staal WegnerBoard member16/04/2024
Jens Bitsch-NørhaveBoard member16/04/2026
Founders
Nimedical Holding ApS, Mattsson Holding af 2008 ApS
Former management (18)
Former management at Evaxion A/S
NameRoleAppointedResigned
Niels Iversen MøllerDirector11/08/200801/04/2022
Lars Aage Staal WegnerChair of the board21/03/201415/12/2014
Thomas William WylonisBoard member21/03/201415/12/2014
Roberto Prego NovoBoard member18/09/201401/06/2018
Lars Aage Staal WegnerBoard member16/12/201401/07/2017
Thomas William WylonisChair of the board16/12/201430/06/2020
Lars Aage Staal WegnerCEO01/07/201701/10/2022
Steven J. ProjanBoard member01/06/201824/05/2023
Jo Ann SuzichBoard member19/07/201925/05/2021
Kim BjørnstrupChair of the board30/06/202004/11/2020
Helen Marie BoudreauBoard member30/06/202025/05/2021
Niels Iversen MøllerBoard member03/05/202230/06/2024
Bo Løkke KarmarkDirector23/05/202201/08/2023
Per Göran Oskar NorlénCEO01/10/202231/08/2023
Jesper Nyegaard NissenDirector01/08/202331/10/2024
Christian KanstrupCEO01/09/202330/06/2025
Helen Katrina Tayton-MartinBoard member30/04/202524/11/2025
Birgitte RønøCEO01/07/202523/11/2025

Signing rule: Virksomheden tegnes af den administrerende direktør og en direktør i forening, eller den administrerende direktør og et medlem af bestyrelsen i forening, eller af den samlede bestyrelse.

Address and production units

1 active production units

Dr Neergaards Vej 5F
2970 Hørsholm

Rudersdal Municipality · Postcode 2970

Production units
Production unitAddressEmployeesP number
Evaxion A/SDr Neergaards Vej 5F, 2970 Hørsholm461014752176

Purpose

Virksomhedens formål er at skabe avanceret software med henblik på udvikling af nye immunterapier og vacciner.

The purpose is quoted from the register in Danish.

Changes year by year

194 registered events
20268 changescapital 6 · accounts 1 · management 1
  • Share capital changed from 115,095,102 DKK to 115,283,514 DKK
  • Share capital changed from 112,964,777 DKK to 115,095,102 DKK
  • Share capital changed from 112,768,539 DKK to 112,964,777 DKK
  • Share capital changed from 110,933,302 DKK to 112,768,539 DKK
  • Share capital changed from 110,565,252 DKK to 110,933,302 DKK
  • Share capital changed from 104,252,689 DKK to 110,565,252 DKK
  • Annual report for 2025 published
  • Jens Bitsch-Nørhave appointed board member
202534 changesmanagement 6 · capital 21 · accounts 1 · name 1 · ownership 4 · industry 1
  • Helen Katrina Tayton-Martin appointed ceo
  • Helen Katrina Tayton-Martin stepped down as board member
  • Birgitte Rønø stepped down as ceo
  • Share capital changed from 103,783,939 DKK to 104,252,689 DKK
  • Share capital changed from 103,705,814 DKK to 103,783,939 DKK
  • Share capital changed from 103,637,064 DKK to 103,705,814 DKK
  • Share capital changed from 103,587,064 DKK to 103,637,064 DKK
  • Share capital changed from 103,080,814 DKK to 103,587,064 DKK
  • Share capital changed from 102,512,064 DKK to 103,080,814 DKK
  • Share capital changed from 101,174,564 DKK to 102,512,064 DKK
  • Share capital changed from 99,554,714 DKK to 101,174,564 DKK
  • Share capital changed from 99,048,464 DKK to 99,554,714 DKK
  • Share capital changed from 98,783,464 DKK to 99,048,464 DKK
  • Share capital changed from 97,845,964 DKK to 98,783,464 DKK
  • Share capital changed from 97,439,714 DKK to 97,845,964 DKK
  • Share capital changed from 97,108,427 DKK to 97,439,714 DKK
  • Share capital changed from 91,682,152 DKK to 97,108,427 DKK
  • Share capital changed from 78,957,152 DKK to 91,682,152 DKK
  • Birgitte Rønø appointed ceo
  • Christian Kanstrup stepped down as ceo
  • Annual report for 2024 published
  • Name changed from EVAXION BIOTECH A/S to Evaxion A/S
  • Helen Katrina Tayton-Martin appointed board member
  • Share capital changed from 78,332,152 DKK to 78,957,152 DKK
  • Share capital changed from 28,365,139 DKK to 78,332,152 DKK
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (90%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) is no longer registered as owner
  • Share capital changed from 19,660,139 DKK to 28,365,139 DKK
  • MATTSSON HOLDING AF 2008 ApS is no longer registered as owner
  • NIMEDICAL HOLDING ApS is no longer registered as owner
  • Share capital changed from 78,640,556 DKK to 19,660,139 DKK
  • Share capital changed from 76,490,556 DKK to 78,640,556 DKK
  • Share capital changed from 70,130,556 DKK to 76,490,556 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202426 changescapital 15 · management 4 · ownership 6 · accounts 1
  • Share capital changed from 63,500,556 DKK to 70,130,556 DKK
  • Share capital changed from 58,660,556 DKK to 63,500,556 DKK
  • Thomas Frederik Schmidt appointed director
  • Jesper Nyegaard Nissen stepped down as director
  • Share capital changed from 57,420,556 DKK to 58,660,556 DKK
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (66.67%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) is no longer registered as owner
  • Share capital changed from 56,850,546 DKK to 57,420,556 DKK
  • Share capital changed from 55,780,546 DKK to 56,850,546 DKK
  • Share capital changed from 55,770,546 DKK to 55,780,546 DKK
  • Share capital changed from 55,760,546 DKK to 55,770,546 DKK
  • Share capital changed from 55,750,546 DKK to 55,760,546 DKK
  • Share capital changed from 54,110,546 DKK to 55,750,546 DKK
  • Niels Iversen Møller stepped down as board member
  • Annual report for 2023 published
  • Lars Aage Staal Wegner appointed board member
  • Share capital changed from 52,150,546 DKK to 54,110,546 DKK
  • Share capital changed from 50,090,546 DKK to 52,150,546 DKK
  • Share capital changed from 44,990,546 DKK to 50,090,546 DKK
  • Share capital changed from 40,540,546 DKK to 44,990,546 DKK
  • MATTSSON HOLDING AF 2008 ApS registered as owner (5%)
  • NIMEDICAL HOLDING ApS registered as owner (5%)
  • NIMEDICAL HOLDING ApS is no longer registered as owner
  • MATTSSON HOLDING AF 2008 ApS is no longer registered as owner
  • Share capital changed from 37,906,996 DKK to 40,540,546 DKK
  • Share capital changed from 37,897,780 DKK to 37,906,996 DKK
202337 changescapital 27 · ownership 4 · management 5 · accounts 1
  • Share capital changed from 28,170,882 DKK to 37,897,780 DKK
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (50%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) is no longer registered as owner
  • Share capital changed from 28,105,158 DKK to 28,170,882 DKK
  • Share capital changed from 28,080,842 DKK to 28,105,158 DKK
  • Share capital changed from 28,015,756 DKK to 28,080,842 DKK
  • Share capital changed from 27,938,637 DKK to 28,015,756 DKK
  • Share capital changed from 27,919,250 DKK to 27,938,637 DKK
  • Share capital changed from 27,868,969 DKK to 27,919,250 DKK
  • Share capital changed from 27,814,140 DKK to 27,868,969 DKK
  • Share capital changed from 27,768,333 DKK to 27,814,140 DKK
  • Share capital changed from 27,716,583 DKK to 27,768,333 DKK
  • Share capital changed from 27,662,484 DKK to 27,716,583 DKK
  • Share capital changed from 27,651,648 DKK to 27,662,484 DKK
  • Christian Kanstrup appointed ceo
  • Per Göran Oskar Norlén stepped down as ceo
  • Jesper Nyegaard Nissen appointed director
  • Bo Løkke Karmark stepped down as director
  • Share capital changed from 27,640,300 DKK to 27,651,648 DKK
  • Share capital changed from 27,635,476 DKK to 27,640,300 DKK
  • Annual report for 2022 published
  • Share capital changed from 26,773,862 DKK to 27,635,476 DKK
  • Share capital changed from 26,623,862 DKK to 26,773,862 DKK
  • Share capital changed from 26,572,737 DKK to 26,623,862 DKK
  • Steven J. Projan stepped down as board member
  • Share capital changed from 26,438,007 DKK to 26,572,737 DKK
  • Share capital changed from 26,421,727 DKK to 26,438,007 DKK
  • Share capital changed from 26,378,919 DKK to 26,421,727 DKK
  • Share capital changed from 25,375,117 DKK to 26,378,919 DKK
  • Share capital changed from 25,278,846 DKK to 25,375,117 DKK
  • Share capital changed from 25,207,168 DKK to 25,278,846 DKK
  • Share capital changed from 25,127,511 DKK to 25,207,168 DKK
  • Share capital changed from 24,868,104 DKK to 25,127,511 DKK
  • Share capital changed from 24,773,826 DKK to 24,868,104 DKK
  • Share capital changed from 24,139,413 DKK to 24,773,826 DKK
  • NIMEDICAL HOLDING ApS registered as owner (10%)
  • NIMEDICAL HOLDING ApS is no longer registered as owner
202221 changescapital 13 · management 5 · ownership 2 · accounts 1
  • Share capital changed from 24,134,963 DKK to 24,139,413 DKK
  • Share capital changed from 24,092,330 DKK to 24,134,963 DKK
  • Share capital changed from 24,027,729 DKK to 24,092,330 DKK
  • Share capital changed from 24,001,333 DKK to 24,027,729 DKK
  • Share capital changed from 23,977,928 DKK to 24,001,333 DKK
  • Per Göran Oskar Norlén appointed ceo
  • Lars Aage Staal Wegner stepped down as ceo
  • Share capital changed from 23,967,092 DKK to 23,977,928 DKK
  • Share capital changed from 23,926,007 DKK to 23,967,092 DKK
  • Share capital changed from 23,833,694 DKK to 23,926,007 DKK
  • Share capital changed from 23,816,430 DKK to 23,833,694 DKK
  • Share capital changed from 23,387,858 DKK to 23,816,430 DKK
  • Share capital changed from 23,350,193 DKK to 23,387,858 DKK
  • MATTSSON HOLDING AF 2008 ApS registered as owner (10%)
  • Share capital changed from 23,257,880 DKK to 23,350,193 DKK
  • MATTSSON HOLDING AF 2008 ApS is no longer registered as owner
  • Bo Løkke Karmark appointed director
  • Annual report for 2021 published
  • Niels Iversen Møller appointed board member
  • Share capital changed from 23,203,808 DKK to 23,257,880 DKK
  • Niels Iversen Møller stepped down as director
202121 changescapital 5 · ownership 10 · address 2 · accounts 1 · management 3
  • Share capital changed from 23,184,656 DKK to 23,203,808 DKK
  • Share capital changed from 23,141,524 DKK to 23,184,656 DKK
  • Share capital changed from 19,198,668 DKK to 23,141,524 DKK
  • MATTSSON HOLDING AF 2008 ApS registered as owner (15%)
  • NIMEDICAL HOLDING ApS registered as owner (15%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (50%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) is no longer registered as owner
  • NIMEDICAL HOLDING ApS is no longer registered as owner
  • MATTSSON HOLDING AF 2008 ApS is no longer registered as owner
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (25%)
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) is no longer registered as owner
  • Moved to Dr Neergaards Vej 5F, 2970 Hørsholm
  • Annual report for 2020 published
  • Lars Holtug appointed board member
  • Helen Marie Boudreau stepped down as board member
  • Jo Ann Suzich stepped down as board member
  • Share capital changed from 16,198,668 DKK to 19,198,668 DKK
  • BNY (Nominees) Limited (as nominee of The Bank of New York Mellon) registered as owner (15%)
  • Punga Punga C.V. is no longer registered as owner
  • Moved to Dr Neergaards Vej 5F, 2970 Hørsholm
  • Share capital changed from 899,926 DKK to 16,198,668 DKK
20208 changesmanagement 5 · capital 3
  • Marianne Søgaard appointed chair of the board
  • Kim Bjørnstrup stepped down as chair of the board
  • Share capital changed from 884,974 DKK to 899,926 DKK
  • Share capital changed from 843,564 DKK to 884,974 DKK
  • Share capital changed from 843,566 DKK to 843,564 DKK
  • Kim Bjørnstrup appointed chair of the board
  • Helen Marie Boudreau appointed board member
  • Thomas William Wylonis stepped down as chair of the board
20197 changescapital 3 · management 1 · ownership 2 · name 1
  • Share capital changed from 836,996 DKK to 843,566 DKK
  • Share capital changed from 717,614 DKK to 836,996 DKK
  • Jo Ann Suzich appointed board member
  • Fidaco Investments C.V. is no longer registered as owner
  • Medicina Argos, S.A. is no longer registered as owner
  • Name changed from EVAXION BIOTECH ApS to EVAXION BIOTECH A/S
  • Share capital changed from 358,807 DKK to 717,614 DKK
20183 changesmanagement 3
  • Steven J. Projan appointed board member
  • Roberto Prego Pineda appointed board member
  • Roberto Prego Novo stepped down as board member
20176 changesaddress 1 · ownership 1 · capital 1 · management 2 · industry 1
  • Moved to Bredgade 34E, 1260 København K
  • Fidaco Investments C.V. registered as owner (5%)
  • Share capital changed from 342,881 DKK to 358,807 DKK
  • Lars Aage Staal Wegner appointed ceo
  • Lars Aage Staal Wegner stepped down as board member
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20161 changecapital 1
  • Share capital changed from 336,549 DKK to 342,881 DKK
20151 changecapital 1
  • Share capital changed from 316,751 DKK to 336,549 DKK
201413 changescapital 2 · ownership 2 · management 7 · address 1 · name 1
  • Share capital changed from 268,148 DKK to 316,751 DKK
  • Punga Punga C.V. registered as owner (5%)
  • Thomas William Wylonis appointed chair of the board
  • Lars Aage Staal Wegner appointed board member
  • Lars Aage Staal Wegner stepped down as chair of the board
  • Thomas William Wylonis stepped down as board member
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Roberto Prego Novo appointed board member
  • Name changed from NOVVAC ApS to EVAXION BIOTECH ApS
  • Share capital changed from 250,000 DKK to 268,148 DKK
  • Lars Aage Staal Wegner appointed chair of the board
  • Thomas William Wylonis appointed board member
  • Medicina Argos, S.A. registered as owner (5%)
20131 changeaddress 1
  • Moved to Toldbodgade 38B, st. th, 1253 København K
20111 changeaddress 1
  • Moved to Ferlevej 100, 3250 Gilleleje
20101 changeaddress 1
  • Moved to Ole Maaløes Vej 3, 2200 København N
20085 changesfounded 1 · management 2 · ownership 2
  • Registered as NOVVAC ApS
  • Niels Iversen Møller appointed director
  • Andreas Holm Mattsson appointed director
  • NIMEDICAL HOLDING ApS registered as owner (20%)
  • MATTSSON HOLDING AF 2008 ApS registered as owner (20%)

Related companies

Same industry in Rudersdal

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction